Knowledge (XXG)

Gastrointestinal stromal tumor

Source 📝

738: 873:(swollen lymph nodes) is uncommon (<10%) and thus imaging usually shows absence of lymph node enlargement. If metastases are not present, other radiologic features suggesting malignancy include: size (>5 cm), heterogeneous enhancement after contrast administration, and ulcerations. Also, overtly malignant behavior (in distinction to malignant potential of lesser degree) is less commonly seen in gastric tumors, with a ratio of behaviorally benign to overtly malignant of 3-5:1. Even if radiographic malignant features are present, these findings may also represent other tumors and definitive diagnosis must be made 673: 730:
abnormal, an MRI or CT scan must follow since it is impossible to evaluate abdominal cavities and other abdominal organs with a barium swallow alone. In a CT scan, abnormalities may be seen in 87% of patients and it should be made with both oral and intravenous contrast. Among imaging studies, MRI has the best tissue contrast, which aids in the identification of masses within the GI tract (intramural masses). Intravenous contrast material is needed to evaluate lesion vascularity.
886: 158:) would be reclassified as GISTs on the basis of immunohistochemical staining. All GIST tumors are now considered to have malignant potential, and no GIST tumor can be definitively classified as "benign". Hence, all GISTs are eligible for cancer staging in the AJCC (7th edition) / UICC. Nonetheless, different GISTs have different risk assessments of their tendency to recur or to metastasize, dependent on their site of origin, size, and number of mitotic figures. 906:
specialized instruments, has been shown to be effective for removal of these tumors without needing large incisions. Resection of the tumor with a 1-cm margin is sufficient and more radical resections add morbidity without benefit. The clinical issues of exact surgical indications for tumor size are controversial. The decision of appropriate laparoscopic surgery is affected by tumor size, location, and growth pattern.
32: 689: 976:
assessment based on pathological factors such as tumor size, mitotic rate and location, can be used to predict the risk of recurrence in GIST patients. Tumors <2 cm with a mitotic rate of <5/50 HPF have been shown to have lower risk of recurrence than larger or more aggressive tumors. Following surgical resection of GISTs,
556: 541: 1015:
Adult GISTs are rare before age 40. Pediatric GISTs are considered to be biologically distinct. Unlike GISTs at other ages, pediatric GISTs are more common in girls and young women. They appear to lack oncogenic activating tyrosine kinase mutations in both KIT and PDGFRA. Pediatric GISTs are treated
614:
to identify the characteristics of GISTs (spindle cells in 70-80%, epitheloid aspect in 20-30%). Smaller tumors can usually be confined to the muscularis propria layer of the intestinal wall. Large ones grow, mainly outward, from the bowel wall until the point where they outstrip their blood supply
782:
studies, these GISTs most commonly present with smooth borders forming right or obtuse angles with the nearby bowel wall, as seen with any other intramural mass. The mucosal surface is usually intact except for areas of ulceration, which are generally present in 50% of GISTs. Ulcerations fill with
729:
are commonly used to evaluate the patient with abdominal complaints. Barium swallow images show abnormalities in 80% of GIST cases. However, some GISTs may be located entirely outside the lumen of the bowel and will not be appreciated with a barium swallow. Even in cases when the barium swallow is
665:. Features of GIST vary depending on tumor size and organ of origin. The diameter can range from a few millimeters to more than 30 cm. Larger tumors usually cause symptoms in contrast to those found incidentally which tend to be smaller and have better prognosis. Large tumors tend to exhibit 145:
of GIST, particularly c-KIT. Historically, literature reviews prior to the molecular definition of GIST, and for a short time thereafter, asserted that 70-80% of GISTs were benign. The identification of a molecular basis for GIST led to the exclusion of many tumors that had been considered as GIST
905:
may be considered in small tumors in carefully selected situations. Post-surgical adjuvant treatment may be recommended. Lymph node metastases are rare, and routine removal of lymph nodes is typically not necessary. Laparoscopic surgery, a minimally invasive abdominal surgery using telescopes and
531:
Lesser numbers of GISTs appear to be associated with neither c-KIT nor PDGFR-Îą abnormalities. About 10-15% of gastrointestinal stromal tumors (GISTs) carry wild-type sequences in all hot spots of KIT and platelet-derived growth factor receptor alpha (PDGFRA) (wt-GISTs). These tumors are currently
975:
A substantial proportion of GIST tumors have a high risk of recurrence as estimated by a number of validated risk stratification schemes, and can be considered for adjuvant therapy. The selection criteria underpinning the decision for possible use of imatinib in these settings, including a risk
808:
of the bowel. In that case, barium swallow may show an air, air-fluid levels or oral contrast media accumulation within these areas. Mucosal ulcerations may also be present. In contrast-enhanced CT images, large GISTs appear as heterogeneous masses due to areas of living tumor cells surrounding
963:
treatment setting, the majority of GIST tumors are cured by surgery, and do not need adjuvant therapy. An exception to this is where the anatomical position of the tumour means that surgery is technically difficult or complex. For example, rectal GIST often requires radical surgery to achieve
733:
Preferred imaging modalities in the evaluation of GISTs are CT and MRI, and, in selected situations, endoscopic ultrasound. CT advantages include its ability to demonstrate evidence of nearby organ invasion, ascites, and metastases. The ability of an MRI to produce images in multiple planes is
1016:
differently from adult GISTs. Although the generally accepted definition of pediatric GIST is a tumor that is diagnosed at the age of 18 years or younger, "pediatric-type" GISTs can be seen in adults, which affects risk assessment, the role of lymph node resection, and choice of therapy.
1004:
GISTs occur in 10-20 per one million people. The true incidence might be higher, as novel laboratory methods are much more sensitive in diagnosing GISTs. The estimated incidence of GIST in the United States is approximately 5000 cases annually. This makes GIST the most common form of
795:
As the tumor grows it may project outside the bowel (exophytic growth) and/or inside the bowel (intraluminal growth), but they most commonly grow exophytically such that the bulk of the tumor projects into the abdominal cavity. If the tumor outstrips its blood supply, it can
813:
studies, the degree of necrosis and bleeding affects the signal intensity pattern. Areas of bleeding within the tumor will vary its signal intensity depending on how long ago the bleeding occurred. The solid portions of the tumor are typically low signal intensity on
993:-1-associated wild-type GIST. A specific subtype of PDGFRA mutation, D842V, is also insensitive to imatinib. Recently, in PDGFRA-mutated GIST, avapritinib has been approved by FDA. Now there are real-world data coming for avapritinib as well 2931: 2916: 2889: 748:
in GIST, which is negative as there is only staining of cytoplasm but not of cell nuclei. Negative nuclear β-catenin staining is seen in approximately 95% of GIST cases, and helps in distinguishing such tumors from β-catenin positive
1434:"The triad of paragangliomas, gastric stromal tumours and pulmonary chondromas (Carney triad), and the dyad of paragangliomas and gastric stromal sarcomas (Carney-Stratakis syndrome): molecular genetics and clinical implications" 2054:
Lee, Chung-Ho; Hyun, Myung-Han; Kwon, Ye-Ji; Cho, Sung-Il; Park, Sung-Soo (2012). "Deciding Laparoscopic Approaches for Wedge Resection in Gastric Submucosal Tumors: A Suggestive Flow Chart Using Three Major Determinants".
138:, and later CD117, were identified as markers that could distinguish the various types. Additionally, in the absence of specific therapy, the diagnostic categorization had only a limited influence on prognosis and therapy. 1334:
Parab, Trisha M.; DeRogatis, Michael J.; Boaz, Alexander M.; Grasso, Salvatore A.; Issack, Paul S.; Duarte, David A.; Urayeneza, Olivier; Vahdat, Saloomeh; Qiao, Jian-Hua; Hinika, Gudata S. (February 2019).
2781:
Serrano C, Martín-Broto J, Asencio-Pascual JM, López-Guerrero JA, Rubió-Casadevall J, BaguÊ S, García-Del-Muro X, Fernåndez-Hernåndez JÁ, Herrero L, López-Pousa A, Poveda A, Martínez-Marín V (August 2023).
1180:
Burkill GJ, Badran M, Al-Muderis O, Meirion Thomas J, Judson IR, Fisher C, Moskovic EC (2003). "Malignant gastrointestinal stromal tumor: distribution, imaging features, and pattern of metastatic spread".
983:
Imatinib was approved for metastatic and unresectable GIST by the US FDA, February 1, 2002. The two-year survival of patients with advanced disease has risen to 75–80% following imatinib treatment.
3609: 2638:
Rege TA, Wagner AJ, Corless CL, Heinrich MC, Hornick JL (Apr 2011). ""Pediatric-type" gastrointestinal stromal tumors in adults: distinctive histology predicts genotype and clinical behavior".
2324:"Approval summary: imatinib mesylate for one or three years in the adjuvant treatment of gastrointestinal stromal tumors. U.S. Food and Drug Administration, Silver Spring, MD 20993-0002, USA" 4101: 2407: 4318: 2946: 1730:
Carlson JW, Fletcher CD (2007). "Immunohistochemistry for beta-catenin in the differential diagnosis of spindle cell lesions: analysis of a series and review of the literature".
3046: 972:. In these situations, the use of neoadjuvant imatinib can significantly decrease both tumour size and mitotic activity, and permit less radical sphincter-preserving surgery. 996:
Regorafenib (Stivarga) was FDA-approved in 2013 for advanced GISTs that cannot be surgically removed and that no longer respond to imatinib (Gleevec) and sunitinib (Sutent).
989:
The effectiveness of imatinib and sunitinib depend on the genotype. c-KIT- and PDGFRA-mutation negative GIST tumors are usually resistant to treatment with imatinib, as is
493:
KIT-p.D419del (exon 8) — A subset of gastrointestinal stromal tumors previously regarded as wild-type tumors carries somatic activating mutations in KIT exon 8 (p.D419del).
4237: 980:
treatment with imatinib reduces the risk of disease recurrence in higher risk groups. In selected higher risk adjuvant situations, imatinib is recommended for 3 years.
3957: 3602: 2456: 3661: 1484:
Huss, S; KĂźnstlinger, H; Wardelmann, E; Kleine, M. A.; Binot, E; Merkelbach-Bruse, S; RĂźdiger, T; Mittler, J; Hartmann, W; BĂźttner, R; Schildhaus, H. U. (2013).
707:
mass altering the shape of the gastric air shadow. Intestinal GISTs may displace loops of bowel and larger tumors may obstruct the bowel and films will show an
3702: 3277: 111:
positively for KIT (CD117). Most (66%) occur in the stomach and gastric GISTs have a lower malignant potential than tumors found elsewhere in the GI tract.
737: 699:
are not very helpful in the evaluation of GISTs. If an abnormality is seen, it will be an indirect sign due to the tumor mass effect on adjacent organs. On
4118: 3595: 2579:
Kelly L, Bryan K, Kim SY, Janeway KA, Killian JK, Schildhaus HU, Miettinen M, Helman L, Meltzer PS, van de Rijn M, Debiec-Rychter M, O'Sullivan M (2013).
1685:
Shojaku H, Futatsuya R, Seto H, et al. (1997). "Malignant gastrointestinal stromal tumor of the small intestine: radiologic-pathologic correlation".
4114: 3686: 4367: 4143: 4018: 3302: 340: 2525: 1245:"Gastrointestinal stromal tumors--definition, clinical, histological, immunohistochemical, and molecular genetic features and differential diagnosis" 3984: 3769: 3039: 1486:"A subset of gastrointestinal stromal tumors previously regarded as wild-type tumors carries somatic activating mutations in KIT exon 8 (p.D419del)" 1921: 1138:
Miettinen M, Lasota J (2006). "Gastrointestinal stromal tumors: review on morphology, molecular pathology, prognosis, and differential diagnosis".
4203: 3746: 3697: 3527: 649:
If the CD117 stain is negative and suspicion remains that the tumor is a GIST, the newer antibody DOG-1 (Discovered On GIST-1) can be used. Also,
2860: 1639:
Pidhorecky I, Cheney RT, Kraybill WG, Gibbs JF (2000). "Gastrointestinal stromal tumors: current diagnosis, biologic behavior, and management".
3387: 1290:
Raut, Chandrajit; Dematteo, Ronald (March 2008). "Evidence-Guided Surgical Management of GIST: Beyond a Simple Case of Benign and Malignant".
4155: 4022: 3998: 2686:"Gastrointestinal stromal tumors (GIST): c-KIT mutations, CD117 expression, differential diagnosis and targeted cancer therapy with Imatinib" 2104: 1117: 4343: 4258: 4220: 3815: 3792: 955:
mutations and PDGFRA mutations other than D842V, and is useful in treating GISTs in several situations. Imatinib has been used in selected
3911: 3883: 3867: 3576: 3532: 3032: 2961: 2476:"Avapritinib in advanced gastrointestinal stromal tumor: case series and review of the literature from a tertiary care center in India" 2230:
Joensuu, Heikki (2012-10-22). "Adjuvant therapy for high-risk gastrointestinal stromal tumour: considerations for optimal management".
1012:
The majority of GISTs present at ages 50–70 years. Across most of the age spectrum, the incidence of GIST is similar in men and women.
3993: 447:, leading to a high cell division rate and possibly genomic instability. Additional mutations are likely "required" for a cell with a 1792:
Levine MS, Buck JL, Pantongrag-Brown L, et al. (1996). "Leiomyosarcoma of the esophagus: radiographic findings in 10 patients".
4330: 4106: 3666: 3139: 986:
If resistance to imatinib is encountered, the multiple tyrosine kinase inhibitor sunitinib (marketed as Sutent) can be considered.
734:
helpful in determining the bowel as the organ of origin (which is difficult when the tumor is very large), facilitating diagnosis.
2371:
Patel Shreyaskumar R; Wong Patrick (2009). "The Efficacy of Imatinib in Unresectable/Metastatic Gastrointestinal Stromal Tumors".
809:
bleeding, necrosis or cysts, which is radiographically seen as a peripheral enhancement pattern with a low attenuation center. In
4399: 4191: 4179: 3435: 2581:"Post-Transcriptional Dysregulation by miRNAs Is Implicated in the Pathogenesis of Gastrointestinal Stromal Tumor [GIST]" 2123:
Wilkinson MJ, Fitzgerald JE, Strauss DC, Hayes AJ, Thomas JM, Messiou C, Fisher C, Benson C, Tekkis PP, Judson I (August 2015).
692:
Non-enhanced CT image of a small GIST in the posterior stomach wall (arrow). The lesion appears subserosal. Incidental finding.
4378: 4308: 4061: 3674: 3945: 913:
medications, with responses in less than 5%. However, several medications have been identified for clinical benefit in GIST:
583:
in cell nuclei is a consistent finding in uterine leiomyomas, and helps in distinguishing such tumors from β-catenin positive
161:
Due to the change in definition, clinical pathways of care before the year 2000 are largely uninformative in the current era.
4129: 3734: 3537: 3297: 3268: 519: 3248: 4313: 4276: 1718:
NCCN Clinical Practice Guidelines in Oncology Soft Tissue Sarcomas, version 3.2012. National Comprehensive Cancer Network.
750: 584: 4242: 3566: 3240: 3153: 3063: 941: 127: 84: 672: 532:
defined by having no mutations in exons 9, 11, 13, and 17 of the KIT gene and exons 12, 14, and 18 of the PDGFRA gene.
4355: 3506: 3282: 3258: 249: 174: 4230: 3904: 3892: 3244: 4293: 4076: 3627: 3522: 3263: 3117: 2011:
Nguyen SQ, Divino CM, Wang JL, Dikman SH (May 2006). "Laparoscopic management of gastrointestinal stromal tumors".
965: 815: 810: 135: 92: 4167: 3741: 3722: 3654: 3430: 3359: 3055: 784: 726: 563: 298: 245:(in 30% of cases). Less common areas of metastasis include the lungs, subcutaneous tissue, lymph nodes or bones. 146:
previously, and also the incorporation of a much larger number of tumors that had been labeled as other types of
4036: 615:
and necrose (die) on the inside, forming a cavity that may eventually come to communicate with the bowel lumen.
4084: 3846: 3787: 3382: 3236: 2972: 696: 253: 1216:
Nishida T, Hirota S (2000). "Biological and clinical review of stromal tumors in the gastrointestinal tract".
4089: 3924: 3571: 3320: 3089: 2730:"Gastrointestinal stromal tumors (GIST): a model for molecule-based diagnosis and treatment of solid tumors" 1891:"Gastrointestinal stromal tumours: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up" 945: 332: 317: 2854: 2523: 3836: 3830: 3670: 3412: 3200: 3162: 3072: 3012: 778:
perspective), small GIST imaging usually suggest a submucosal process or a mass within the bowel wall. In
521: 366: 134:
were unable to specifically distinguish among types now known to be dissimilar molecularly. Subsequently,
56: 2866: 1535:"Wnt/β-catenin signaling pathway in uterine leiomyoma: role in tumor biology and targeting opportunities" 618:
When GIST is suspected—as opposed to other causes for similar tumors—the pathologist can use
4297: 3690: 3618: 2845:
SPAEN (Sarcoma Patients EuroNet) - European Network of Sarcoma, GIST and Desmoid Patient Advocacy Groups
2172:
Joensuu, Heikki (2012-06-01). "Adjuvant treatment of GIST: patient selection and treatment strategies".
1386:
Agaimy A, Hartmann A (2010). "Hereditary and non-hereditary syndromic gastointestinal stromal tumours".
1108:
Demetri, G. (2011). "Gastrointestinal Stromal Tumor". In DeVita, L; Lawrence, TS; Rosenberg, SA (eds.).
858: 432: 386: 328: 3272: 3718: 3649: 3417: 2592: 741: 661:
The purpose of radiologic imaging is to locate the lesion, evaluate for signs of invasion and detect
619: 576: 108: 4032: 4028: 3709: 937: 1719: 885: 787:, small GISTs are seen as smooth, sharply defined intramural masses with homogeneous attenuation. 150:
and undifferentiated carcinomas. For example, some previous diagnoses of stomach and small bowel
4006: 3477: 3459: 3399: 3228: 3224: 2769: 2716: 2663: 2388: 2263: 2205: 2154: 2036: 1664: 1614: 1411: 1307: 1272: 142: 39:
Histopathologic image of gastrointestinal stromal tumor of the stomach. Hematoxylin-eosin stain.
901:
feasible, surgery is the primary treatment of choice. Surgery can be potentially curative, but
4047: 3920: 3896: 3876: 3872: 3544: 3496: 3487: 3210: 3112: 3081: 2983: 2910: 2906: 2902: 2813: 2761: 2708: 2655: 2620: 2561: 2505: 2353: 2304: 2255: 2247: 2197: 2189: 2146: 2100: 2072: 2028: 1963: 1912: 1871: 1836: 1809: 1774: 1747: 1694: 1656: 1606: 1564: 1515: 1463: 1403: 1368: 1264: 1225: 1198: 1155: 1113: 1065: 990: 708: 487: 393: 321: 313: 277: 273: 272:
familial or idiopathic multitumor syndromes. These include, in descending order of frequency,
198: 182: 44: 2898: 684:
and protrudes intraluminally. Upper GI bleeding led to endoscopy, finding an ulcerated mass.
3940: 3935: 3900: 3860: 3632: 3345: 3219: 3134: 3122: 2803: 2795: 2751: 2741: 2700: 2647: 2610: 2600: 2553: 2495: 2487: 2380: 2343: 2335: 2294: 2239: 2181: 2136: 2125:"Surgical treatment of gastrointestinal stromal tumour of the rectum in the era of imatinib" 2064: 2020: 1993: 1953: 1945: 1902: 1863: 1827:
Tervahartiala P, Halavaara J (1998). "Radiology of GIST. Gastrointestinal stromal tumours".
1801: 1739: 1648: 1598: 1554: 1546: 1505: 1497: 1453: 1445: 1395: 1358: 1348: 1299: 1256: 1190: 1147: 1055: 1045: 909:
Radiotherapy has not historically been effective for GISTs and GISTs do not respond to most
902: 603: 428: 424: 370: 269: 95:, or similar cells. They are defined as tumors whose behavior is driven by mutations in the 61: 2429: 3928: 3187: 3170: 2529: 952: 874: 870: 842: 819: 805: 775: 767: 700: 467: 436: 400:. The c-KIT product/CD117 is expressed on ICCs and a large number of other cells, mainly 234: 218: 185:
is rare, due to the tumor's outward pattern of growth. Often, there is a history of vague
2940: 2808: 2783: 2756: 2729: 2596: 1589:
Hersh MR, Choi J, Garrett C, Clark R (2005). "Imaging Gastrointestinal Stromal Tumors".
4254: 4162: 4094: 3916: 3888: 3501: 3464: 3394: 3292: 3232: 3175: 3104: 3094: 2955: 2951: 2746: 2615: 2580: 2500: 2475: 2348: 2323: 1958: 1933: 1854:
Ulusan S, Koc Z, Kayaselcuk F (2008). "Gastrointestinal stromal tumours: CT findings".
1559: 1534: 1510: 1485: 1458: 1433: 1363: 1336: 1060: 1033: 862: 850: 779: 763: 722: 650: 630:—see below). 95% of all GISTs are CD117-positive (other possible markers include 611: 479: 397: 238: 186: 151: 131: 2068: 1765:
Lehnert T (1998). "Gastrointestinal sarcoma (GIST)--a review of surgical management".
4393: 4262: 3952: 3714: 3587: 3445: 3127: 2243: 1984:
Rice, Daniel; Rattner, David (2024). "Laparoscopic resection of gastric GIST tumor".
1743: 1449: 977: 960: 826:. Signal-intensity voids are present if there is gas within areas of necrotic tumor. 716: 681: 291: 155: 88: 2773: 2667: 2392: 2339: 2267: 2209: 2040: 1618: 1311: 189:
or discomfort, and the tumor has become rather large by time the diagnosis is made.
4271: 4198: 3681: 3407: 2720: 2430:"News: Genetic Variations in GI Tumors Determine Which Medications Are Efficacious" 2158: 1415: 1276: 910: 704: 385:
of the gene itself; a smaller subset of c-KIT-associated GISTs are associated with
325: 206: 141:
The understanding of GIST biology changed significantly with identification of the
2457:"FDA approves avapritinib for gastrointestinal stromal tumor with a rare mutation" 2408:"The Use of Tyrosine Kinase Inhibitors for Gastrointestinal Stromal Tumors (GIST)" 1668: 745: 580: 2977: 2651: 2605: 1151: 119:
GIST was introduced as a diagnostic term in 1983. Until the late 1990s, many non-
3472: 3425: 3368: 3312: 956: 930: 922: 607: 401: 104: 2988: 2474:
Verma S, Reddy R, Chandrashekhara SH, Shamim SA, Tripathy S, Rastogi S (2021).
1602: 1550: 31: 3969: 3558: 2799: 2557: 2544:
Pappo AS, Janeway KA (Feb 2009). "Pediatric gastrointestinal stromal tumors".
2384: 2185: 2024: 1949: 1805: 1652: 1501: 1399: 1303: 1194: 926: 898: 846: 823: 801: 783:
barium causing a bull's eye or target lesion appearance. In contrast-enhanced
715:
are present, plain radiographs will show collections of air within the tumor.
712: 669:
behavior but small GISTs may also demonstrate clinically aggressive behavior.
662: 409: 210: 178: 120: 96: 77: 3024: 2251: 2193: 598:, percutaneously with CT or ultrasound guidance or at the time of surgery. A 4186: 4174: 4150: 3454: 3377: 3195: 2935: 2925: 2299: 2282: 1907: 1890: 1353: 1110:
DeVita, Hellman, and Rosenberg's Cancer: Principles and Practice of Oncology
918: 771: 719:
is an unusual feature of GIST but if present can be visible on plain films.
643: 595: 544: 405: 284: 281: 242: 222: 170: 2817: 2765: 2712: 2659: 2624: 2565: 2509: 2491: 2357: 2308: 2259: 2201: 2150: 2076: 2032: 1967: 1916: 1875: 1867: 1751: 1660: 1610: 1568: 1519: 1467: 1407: 1372: 1268: 1229: 1202: 1159: 1069: 688: 1840: 1813: 1778: 1698: 1260: 4304: 4138: 4010: 3517: 3007: 2522:
Pazdur, Richard. FDA Approval for Regorafenib. National Cancer Institute.
1112:(9th ed.). Wolters Kluwer Health/Lippincott Williams & Wilkins. 1032:
Yuan, Z; Chen, J; Zheng, Q; Huang, XY; Yang, Z; Tang, J (7 August 2009).
914: 866: 797: 639: 623: 420: 382: 301: 295: 257: 80: 49: 2881: 2685: 1997: 1050: 2704: 1006: 894: 559:
Same GIST seen on forward view of the endoscope showing overlying clot.
548: 288: 226: 214: 202: 147: 486:
exon 17 are responsible for resistance to targeted therapy drugs like
412:
and several others. In the gut, however, a mass staining positive for
4350: 4056: 4014: 2920: 2893: 2141: 2124: 834: 800:
internally, creating a central fluid-filled cavity with bleeding and
677: 666: 635: 599: 591: 507: 440: 309: 100: 1244: 474:
is important in the medical therapy for GISTs, as described below.
889:
Image showing Gastrointestinal Stromal Tumor after surgical removal
4362: 4338: 3964: 3764: 3729: 2844: 969: 884: 838: 837:
is characterized by local invasion and metastases, usually to the
736: 687: 671: 627: 555: 554: 540: 539: 413: 357: 305: 230: 123: 2836: 256:
of the intestine. They serve a pacemaker function in controlling
4325: 4249: 4225: 3855: 3810: 3514: 2966: 854: 631: 459: 344: 336: 3591: 3028: 2831: 2849: 1934:"Updates on the management of gastrointestinal stromal tumors" 431:, and an intracellular part. Mutations generally occur in the 225:. Small tumors are generally not aggressive, especially when 443:. Mutations make c-KITfunction independent of activation by 1533:
El Sabeh M, Saha SK, Afrin S, Islam MS, Borahay MA (2021).
435:
encoding the intracellular part (exon 11), which acts as a
1337:"Gastrointestinal stromal tumors: a comprehensive review" 2281:
Reichardt P, Blay JY, Boukovinas I, et al. (2012).
355:
Approximately 85% GISTs are associated with an abnormal
320:
of hereditary GIST and paraganglioma, that is caused by
268:
Most GISTs are sporadic. Less than 5% occur as part of
804:
that can eventually ulcerate and communicate into the
653:
of KIT and PDGFRA can be used to prove the diagnosis.
229:
rate is slow. GIST tumors commonly metastasize to the
4319:
Junctional epidermolysis bullosa with pyloric atresia
2784:"GEIS Guidelines for gastrointestinal stromal tumors" 455:
mutation is probably the first step of this process.
2871: 2283:"Adjuvant therapy in primary GIST: state-of-the-art" 1034:"Heterotopic pancreas in the gastrointestinal tract" 510:), which is a related tyrosine kinase. Mutations in 4286: 4213: 4128: 4075: 4046: 3983: 3845: 3829: 3802: 3779: 3756: 3641: 3626: 3557: 3486: 3444: 3367: 3358: 3333: 3311: 3209: 3186: 3161: 3152: 3103: 3080: 3071: 3062: 2998: 2875: 55: 43: 24: 2322:Cohen MH, Johnson JR, Justice R, Pazdur R (2012). 1714: 1712: 1710: 1708: 1009:, which constitutes more than 70 types of cancer. 506:instead have a mutation in another gene, PDGFR-Îą ( 2090: 2088: 2086: 1634: 1632: 1630: 1628: 502:Most GIST cells with wildtype (i.e. not mutated) 3958:Congenital insensitivity to pain with anhidrosis 1427: 1425: 1103: 1101: 1099: 416:is likely to be a GIST, arising from ICC cells. 2095:Kantarjian, HM; Wolff, RA; Koller, CA. (2011). 1479: 1477: 1133: 1131: 1129: 1097: 1095: 1093: 1091: 1089: 1087: 1085: 1083: 1081: 1079: 130:were called "gastrointestinal stromal tumors". 2225: 2223: 2221: 2219: 1680: 1678: 762:Since GISTs arise from the bowel layer called 642:). Other cells that show CD117 positivity are 3603: 3040: 1175: 1173: 1171: 1169: 508:platelet-derived growth factor receptor alpha 8: 3703:Gonadotropin-releasing hormone insensitivity 2728:Kitamura Y, Hirota S, Nishida T (Apr 2003). 2539: 2537: 2434:Genetic Engineering & Biotechnology News 1584: 1582: 1580: 1578: 4119:Congenital amegakaryocytic thrombocytopenia 2057:Journal of the American College of Surgeons 1979: 1977: 893:For localized, resectable adult GISTs, if 4204:Autoimmune lymphoproliferative syndrome 1A 3842: 3687:Follicle-stimulating hormone insensitivity 3638: 3610: 3596: 3588: 3364: 3158: 3077: 3068: 3047: 3033: 3025: 2872: 2867:Cancer.Net: Gastrointestinal Stromal Tumor 2097:The MD Anderson Manual of Medical Oncology 861:have been seen. In distinction to gastric 30: 21: 4368:X-linked severe combined immunodeficiency 4144:TNF receptor associated periodic syndrome 3303:Hereditary nonpolyposis colorectal cancer 2807: 2755: 2745: 2614: 2604: 2499: 2347: 2298: 2140: 1957: 1906: 1558: 1509: 1457: 1362: 1352: 1059: 1049: 451:mutation to develop into a GIST, but the 2857:International GIST Advocacy Organization 849:. However, cases of metastases to bone, 610:physician. The pathologist examines the 590:The definitive diagnosis is made with a 381:pathway most commonly (85%) arises from 4156:Selective immunoglobulin A deficiency 2 3747:Aspirin-exacerbated respiratory disease 3528:Intraductal papillary mucinous neoplasm 2118: 2116: 1024: 4331:EDAR hypohidrotic ectodermal dysplasia 4259:Familial exudative vitreoretinopathy 4 3816:Familial exudative vitreoretinopathy 1 602:sample will be investigated under the 4023:Hereditary hemorrhagic telangiectasia 3999:Persistent MĂźllerian duct syndrome II 3770:Jansen's metaphyseal chondrodysplasia 822:and enhanced after administration of 680:. The lesion appears submucosal, is 466:gene are known to occur in GIST. The 316:. The Carney-Stratakis syndrome is a 252:(ICC), that are normally part of the 7: 4344:Nevoid basal-cell carcinoma syndrome 3793:Familial hypocalciuric hypercalcemia 1432:Stratakis CA, Carney JA (Jul 2009). 1341:Journal of Gastrointestinal Oncology 4107:Surfactant metabolism dysfunction 4 3577:Desmoplastic small round cell tumor 4356:BMPR1A juvenile polyposis syndrome 4277:LDLR Familial hypercholesterolemia 3278:Polymerase proofreading-associated 2747:10.1111/j.1349-7006.2003.tb01439.x 462:11, 9 and rarely 13 and 17 of the 14: 3667:Luteinizing hormone insensitivity 3140:Hereditary diffuse gastric cancer 2174:Nature Reviews. Clinical Oncology 2069:10.1016/j.jamcollsurg.2012.07.009 1038:World Journal of Gastroenterology 3735:Nephrogenic diabetes insipidus 1 3436:Nodular regenerative hyperplasia 2244:10.2165/11635590-000000000-00000 1744:10.1111/j.1365-2559.2007.02794.x 1450:10.1111/j.1365-2796.2009.02110.x 703:, stomach GISTs may appear as a 248:GISTs are thought to arise from 233:(in 28% of cases) and/or to the 3675:Male-limited precocious puberty 2340:10.1634/theoncologist.2012-0109 948:inhibition, also inhibits both 818:, are high signal intensity on 70:Gastrointestinal stromal tumors 4062:Leber's congenital amaurosis 1 3974:Gastrointestinal stromal tumor 3538:Solid pseudopapillary neoplasm 3341:Gastrointestinal stromal tumor 3298:Familial adenomatous polyposis 1243:Miettinen M, Lasota J (2001). 964:complete resection, involving 936:Imatinib (Glivec/Gleevec), an 568: 490:, a tyrosine kinase inhibitor. 25:Gastrointestinal stromal tumor 1: 3346:Krukenberg tumor (metastatic) 2863:Patient Guide to GIST tumors. 2099:(2nd ed.). McGraw-Hill. 566:is often undertaken (see the 365:is a gene that encodes for a 107:kinase (rare). 95% of GISTs 3567:Primary peritoneal carcinoma 3241:traditional serrated adenoma 2684:de Silva CM, Reid R (2003). 2652:10.1097/PAS.0b013e31820e5f7d 2606:10.1371/journal.pone.0064102 1152:10.5858/2006-130-1466-GSTROM 942:chronic myelogenous leukemia 940:drug initially marketed for 207:most gastrointestinal tumors 3655:Congenital hypothyroidism 1 3507:Pancreatic ductal carcinoma 2546:Hematol Oncol Clin North Am 1889:Casali PG, Blay JY (2010). 547:image of GIST in fundus of 369:for a growth factor termed 250:interstitial cells of Cajal 4416: 4314:Glanzmann's thrombasthenia 4294:Immunoglobulin superfamily 3946:Rabson–Mendenhall syndrome 3628:G protein-coupled receptor 3523:Serous microcystic adenoma 3118:Signet ring cell carcinoma 3056:Digestive system neoplasia 2850:GIST Support International 1603:10.1177/107327480501200206 1551:10.1007/s11010-021-04174-6 966:abdominoperineal resection 676:CT image of a GIST in the 93:interstitial cell of Cajal 4168:Hyper-IgM syndrome type 3 3431:Focal nodular hyperplasia 2838:Surgery Questions in GIST 2800:10.1177/17588359231192388 2558:10.1016/j.hoc.2008.11.005 2385:10.17925/ohr.2009.05.1.61 2186:10.1038/nrclinonc.2012.74 2025:10.1007/s00464-005-0435-8 1950:10.1016/j.soc.2011.12.004 1806:10.2214/ajr.167.1.8659399 1653:10.1007/s10434-000-0705-6 1502:10.1038/modpathol.2013.47 1400:10.1007/s00292-010-1354-6 1304:10.1245/s10434-008-9817-1 1195:10.1148/radiol.2262011880 314:Carney-Stratakis syndrome 221:and less than 10% in the 213:. About 70% occur in the 175:gastrointestinal bleeding 38: 29: 4243:Cenani–Lenz syndactylism 4085:Type I cytokine receptor 3723:Hirschsprung's disease 2 3533:Mucinous cystic neoplasm 3383:Hepatocellular carcinoma 3237:sessile serrated adenoma 2406:Okuno, S (14 Sep 2011). 766:(which is deeper to the 626:that stain the molecule 594:, which can be obtained 254:autonomic nervous system 4400:Gastrointestinal cancer 3925:Thanatophoric dysplasia 3719:Waardenburg syndrome 4a 3572:Peritoneal mesothelioma 3321:Squamous cell carcinoma 3090:Squamous cell carcinoma 2861:American Cancer Society 1354:10.21037/jgo.2018.08.20 865:or gastric/small bowel 551:, seen on retroflexion. 518:are mutually exclusive 333:succinate dehydrogenase 276:Recklinghausen (NF-1), 181:(mainly in the liver). 169:GISTs may present with 4379:cell surface receptors 4231:Donnai–Barrow syndrome 3905:Jackson–Weiss syndrome 3893:Antley–Bixler syndrome 3877:KAL2 Kallmann syndrome 3831:Enzyme-linked receptor 3671:Leydig cell hypoplasia 3413:Hepatocellular adenoma 3201:Pseudomyxoma peritonei 2841:ESUN (August 15, 2006) 2492:10.2144/fsoa-2020-0178 890: 830:Features of malignancy 754: 693: 685: 560: 552: 367:transmembrane receptor 331:pathway involving the 183:Intestinal obstruction 128:gastrointestinal tract 85:gastrointestinal tract 76:) are the most common 57:Differential diagnosis 16:Human disease (cancer) 3691:XX gonadal dysgenesis 3619:Cell surface receptor 2794:: 17588359231192388. 2412:Contemporary Oncology 2300:10.1093/annonc/mds198 1908:10.1093/annonc/mdq208 1901:(suppl 5): v98–v102. 1261:10.1007/s004280000338 888: 740: 691: 675: 558: 543: 429:transmembrane segment 387:constitutive activity 329:tumor suppressor gene 87:. GISTs arise in the 4037:Loeys–Dietz syndrome 3418:Cavernous hemangioma 3269:Familial adenomatous 3256:Polyposis syndromes: 1938:Surg Oncol Clin N Am 1868:10.1259/bjr/90134736 742:Immunohistochemistry 620:immunohistochemistry 577:immunohistochemistry 425:extracellular domain 197:GISTs are tumors of 154:(malignant tumor of 2597:2013PLoSO...864102K 1932:Bamboat ZM (2012). 1794:AJR Am J Roentgenol 1140:Arch Pathol Lab Med 1051:10.3748/wjg.15.3701 938:orally administered 723:Barium fluoroscopic 709:obstructive pattern 4007:TGF beta receptors 3478:Gallbladder cancer 3460:Cholangiocarcinoma 3400:Liver angiosarcoma 3334:Upper and/or lower 3283:Serrated polyposis 2999:External resources 2788:Ther Adv Med Oncol 2705:10.1007/BF03033708 2528:2014-07-05 at the 2287:Annals of Oncology 1895:Annals of Oncology 1218:Histol Histopathol 891: 820:T2-weighted images 816:T1-weighted images 764:muscularis propria 755: 694: 686: 561: 553: 439:to activate other 322:germline mutations 171:trouble swallowing 165:Signs and symptoms 4387: 4386: 4071: 4070: 3921:Hypochondroplasia 3897:Pfeiffer syndrome 3873:Pfeiffer syndrome 3825: 3824: 3585: 3584: 3553: 3552: 3545:Pancreatoblastoma 3497:exocrine pancreas 3354: 3353: 3329: 3328: 3148: 3147: 3113:Gastric carcinoma 3022: 3021: 2463:. 9 January 2020. 2293:(11): 2776–2781. 2106:978-0-07-170106-8 1998:10.24296/jomi/129 1829:Ann Chir Gynaecol 1767:Ann Chir Gynaecol 1119:978-1-4511-0545-2 991:neurofibromatosis 959:settings. In the 725:examinations and 697:Plain radiographs 488:imatinib mesylate 458:Mutations in the 423:comprises a long 394:enzymatic pathway 274:neurofibromatosis 199:connective tissue 132:Histopathologists 67: 66: 19:Medical condition 4407: 3941:Donohue syndrome 3901:Crouzon syndrome 3861:Robinow syndrome 3843: 3639: 3612: 3605: 3598: 3589: 3365: 3264:MUTYH-associated 3249:Cronkhite–Canada 3220:Colorectal polyp 3159: 3135:Linitis plastica 3123:Gastric lymphoma 3078: 3069: 3049: 3042: 3035: 3026: 2873: 2821: 2811: 2777: 2759: 2749: 2724: 2693:Pathol Oncol Res 2690: 2672: 2671: 2640:Am J Surg Pathol 2635: 2629: 2628: 2618: 2608: 2576: 2570: 2569: 2541: 2532: 2520: 2514: 2513: 2503: 2471: 2465: 2464: 2453: 2447: 2444: 2438: 2437: 2426: 2420: 2419: 2403: 2397: 2396: 2368: 2362: 2361: 2351: 2319: 2313: 2312: 2302: 2278: 2272: 2271: 2227: 2214: 2213: 2169: 2163: 2162: 2144: 2142:10.1002/bjs.9818 2120: 2111: 2110: 2092: 2081: 2080: 2051: 2045: 2044: 2008: 2002: 2001: 1981: 1972: 1971: 1961: 1929: 1923: 1920: 1910: 1886: 1880: 1879: 1862:(968): 618–623. 1851: 1845: 1844: 1824: 1818: 1817: 1789: 1783: 1782: 1762: 1756: 1755: 1727: 1721: 1716: 1703: 1702: 1682: 1673: 1672: 1636: 1623: 1622: 1586: 1573: 1572: 1562: 1539:Mol Cell Biochem 1530: 1524: 1523: 1513: 1490:Modern Pathology 1481: 1472: 1471: 1461: 1429: 1420: 1419: 1383: 1377: 1376: 1366: 1356: 1331: 1325: 1322: 1316: 1315: 1298:(5): 1542–1543. 1292:Ann. Surg. Oncol 1287: 1281: 1280: 1240: 1234: 1233: 1213: 1207: 1206: 1177: 1164: 1163: 1135: 1124: 1123: 1105: 1074: 1073: 1063: 1053: 1029: 903:watchful waiting 875:immunochemically 527:Wild-type tumors 498:PDGFRA mutations 377:). The abnormal 371:stem cell factor 299:gain-of-function 62:Ectopic pancreas 34: 22: 4415: 4414: 4410: 4409: 4408: 4406: 4405: 4404: 4390: 4389: 4388: 4383: 4287:Other/ungrouped 4282: 4263:Osteopetrosis 1 4209: 4124: 4067: 4042: 3979: 3929:Muenke syndrome 3835: 3833: 3821: 3798: 3775: 3752: 3630: 3622: 3616: 3586: 3581: 3549: 3482: 3440: 3350: 3325: 3307: 3205: 3182: 3171:Duodenal cancer 3163:Small intestine 3144: 3099: 3058: 3053: 3023: 3018: 3017: 2994: 2993: 2884: 2855:Life Raft Group 2828: 2780: 2727: 2688: 2683: 2680: 2678:General sources 2675: 2637: 2636: 2632: 2578: 2577: 2573: 2543: 2542: 2535: 2530:Wayback Machine 2521: 2517: 2473: 2472: 2468: 2455: 2454: 2450: 2446:ASCO-SEP 3rd ed 2445: 2441: 2428: 2427: 2423: 2414:. Spring 2011. 2405: 2404: 2400: 2370: 2369: 2365: 2321: 2320: 2316: 2280: 2279: 2275: 2238:(15): 1953–63. 2229: 2228: 2217: 2171: 2170: 2166: 2122: 2121: 2114: 2107: 2094: 2093: 2084: 2053: 2052: 2048: 2010: 2009: 2005: 1983: 1982: 1975: 1931: 1930: 1926: 1888: 1887: 1883: 1853: 1852: 1848: 1826: 1825: 1821: 1791: 1790: 1786: 1764: 1763: 1759: 1729: 1728: 1724: 1717: 1706: 1684: 1683: 1676: 1638: 1637: 1626: 1588: 1587: 1576: 1532: 1531: 1527: 1483: 1482: 1475: 1431: 1430: 1423: 1385: 1384: 1380: 1333: 1332: 1328: 1323: 1319: 1289: 1288: 1284: 1242: 1241: 1237: 1224:(4): 1293–301. 1215: 1214: 1210: 1179: 1178: 1167: 1146:(10): 1466–78. 1137: 1136: 1127: 1120: 1107: 1106: 1077: 1031: 1030: 1026: 1022: 1002: 953:tyrosine kinase 899:physiologically 883: 871:lymphadenopathy 859:retroperitoneum 832: 793: 760: 701:abdominal x-ray 659: 538: 529: 500: 480:point mutations 468:tyrosine kinase 437:tyrosine kinase 353: 351:c-KIT mutations 335:(SDH) subunits 280:(gastric GIST, 266: 235:greater omentum 219:small intestine 195: 193:Pathophysiology 167: 152:leiomyosarcomas 143:molecular basis 117: 103:gene (10%), or 20: 17: 12: 11: 5: 4413: 4411: 4403: 4402: 4392: 4391: 4385: 4384: 4382: 4381: 4376: 4372: 4371: 4359: 4347: 4322: 4321: 4316: 4311: 4301: 4300: 4290: 4288: 4284: 4283: 4281: 4280: 4267: 4266: 4255:Worth syndrome 4246: 4234: 4217: 4215: 4214:Lipid receptor 4211: 4210: 4208: 4207: 4195: 4183: 4171: 4159: 4147: 4134: 4132: 4126: 4125: 4123: 4122: 4111: 4110: 4098: 4095:Laron syndrome 4081: 4079: 4073: 4072: 4069: 4068: 4066: 4065: 4052: 4050: 4044: 4043: 4041: 4040: 4026: 4003: 4002: 3989: 3987: 3981: 3980: 3978: 3977: 3970:KIT Piebaldism 3961: 3949: 3943: 3932: 3917:Achondroplasia 3908: 3889:Apert syndrome 3880: 3864: 3851: 3849: 3840: 3827: 3826: 3823: 3822: 3820: 3819: 3806: 3804: 3800: 3799: 3797: 3796: 3783: 3781: 3777: 3776: 3774: 3773: 3760: 3758: 3754: 3753: 3751: 3750: 3738: 3726: 3706: 3694: 3678: 3658: 3645: 3643: 3636: 3624: 3623: 3617: 3615: 3614: 3607: 3600: 3592: 3583: 3582: 3580: 3579: 3574: 3569: 3563: 3561: 3555: 3554: 3551: 3550: 3548: 3547: 3541: 3540: 3535: 3530: 3525: 3510: 3509: 3504: 3502:Adenocarcinoma 3492: 3490: 3484: 3483: 3481: 3480: 3468: 3467: 3465:Klatskin tumor 3462: 3450: 3448: 3442: 3441: 3439: 3438: 3433: 3421: 3420: 3415: 3403: 3402: 3397: 3395:Hepatoblastoma 3392: 3391: 3390: 3373: 3371: 3362: 3356: 3355: 3352: 3351: 3349: 3348: 3343: 3337: 3335: 3331: 3330: 3327: 3326: 3324: 3323: 3317: 3315: 3309: 3308: 3306: 3305: 3300: 3295: 3293:Adenocarcinoma 3286: 3285: 3280: 3275: 3266: 3261: 3252: 3251: 3215: 3213: 3207: 3206: 3204: 3203: 3198: 3192: 3190: 3184: 3183: 3181: 3180: 3179: 3178: 3176:Adenocarcinoma 3167: 3165: 3156: 3150: 3149: 3146: 3145: 3143: 3142: 3137: 3132: 3131: 3130: 3120: 3115: 3109: 3107: 3101: 3100: 3098: 3097: 3095:Adenocarcinoma 3092: 3086: 3084: 3075: 3066: 3060: 3059: 3054: 3052: 3051: 3044: 3037: 3029: 3020: 3019: 3016: 3015: 3003: 3002: 3000: 2996: 2995: 2992: 2991: 2980: 2969: 2958: 2943: 2928: 2913: 2885: 2880: 2879: 2877: 2876:Classification 2870: 2869: 2864: 2858: 2852: 2847: 2842: 2834: 2832:GIST Cancer UK 2827: 2826:External links 2824: 2823: 2822: 2778: 2725: 2679: 2676: 2674: 2673: 2646:(4): 495–504. 2630: 2571: 2533: 2515: 2466: 2448: 2439: 2436:. 13 Nov 2008. 2421: 2398: 2363: 2334:(7): 992–997. 2314: 2273: 2215: 2164: 2135:(8): 965–971. 2112: 2105: 2082: 2063:(6): 831–840. 2046: 2003: 1973: 1924: 1881: 1846: 1819: 1784: 1773:(4): 297–305. 1757: 1732:Histopathology 1722: 1704: 1674: 1641:Ann Surg Oncol 1624: 1597:(2): 111–115. 1591:Cancer Control 1574: 1545:(9): 3513–36. 1525: 1496:(7): 1004–12. 1473: 1421: 1378: 1347:(1): 144–154. 1326: 1317: 1282: 1235: 1208: 1165: 1125: 1118: 1075: 1044:(29): 3701–3. 1023: 1021: 1018: 1001: 998: 968:and permanent 882: 879: 863:adenocarcinoma 831: 828: 792: 789: 780:barium swallow 759: 756: 678:gastric cardia 658: 655: 612:histopathology 596:endoscopically 537: 534: 528: 525: 499: 496: 495: 494: 491: 398:immunoblotting 352: 349: 278:Carney's triad 265: 262: 239:lesser omentum 209:, they are non 194: 191: 187:abdominal pain 166: 163: 116: 115:Classification 113: 65: 64: 59: 53: 52: 47: 41: 40: 36: 35: 27: 26: 18: 15: 13: 10: 9: 6: 4: 3: 2: 4412: 4401: 4398: 4397: 4395: 4380: 4377: 4374: 4373: 4369: 4365: 4364: 4360: 4357: 4353: 4352: 4348: 4345: 4341: 4340: 4336: 4335: 4334: 4332: 4328: 4327: 4320: 4317: 4315: 4312: 4310: 4306: 4303: 4302: 4299: 4295: 4292: 4291: 4289: 4285: 4278: 4274: 4273: 4269: 4268: 4264: 4260: 4256: 4252: 4251: 4247: 4244: 4240: 4239: 4235: 4232: 4228: 4227: 4222: 4219: 4218: 4216: 4212: 4205: 4201: 4200: 4196: 4193: 4189: 4188: 4184: 4181: 4177: 4176: 4172: 4169: 4165: 4164: 4160: 4157: 4153: 4152: 4148: 4145: 4141: 4140: 4136: 4135: 4133: 4131: 4127: 4120: 4116: 4113: 4112: 4108: 4104: 4103: 4099: 4096: 4092: 4091: 4086: 4083: 4082: 4080: 4078: 4074: 4063: 4059: 4058: 4054: 4053: 4051: 4049: 4045: 4038: 4034: 4030: 4027: 4024: 4020: 4016: 4012: 4008: 4005: 4004: 4000: 3996: 3995: 3991: 3990: 3988: 3986: 3982: 3975: 3971: 3967: 3966: 3962: 3959: 3955: 3954: 3950: 3947: 3944: 3942: 3938: 3937: 3933: 3930: 3926: 3922: 3918: 3914: 3913: 3909: 3906: 3902: 3898: 3894: 3890: 3886: 3885: 3881: 3878: 3874: 3870: 3869: 3865: 3862: 3858: 3857: 3853: 3852: 3850: 3848: 3844: 3841: 3838: 3837:growth factor 3832: 3828: 3817: 3813: 3812: 3808: 3807: 3805: 3801: 3794: 3790: 3789: 3785: 3784: 3782: 3778: 3771: 3767: 3766: 3762: 3761: 3759: 3755: 3748: 3744: 3743: 3739: 3736: 3732: 3731: 3727: 3724: 3720: 3716: 3715:ABCD syndrome 3712: 3711: 3707: 3704: 3700: 3699: 3695: 3692: 3688: 3684: 3683: 3679: 3676: 3672: 3668: 3664: 3663: 3659: 3656: 3652: 3651: 3647: 3646: 3644: 3640: 3637: 3634: 3629: 3625: 3620: 3613: 3608: 3606: 3601: 3599: 3594: 3593: 3590: 3578: 3575: 3573: 3570: 3568: 3565: 3564: 3562: 3560: 3556: 3546: 3543: 3542: 3539: 3536: 3534: 3531: 3529: 3526: 3524: 3520: 3519: 3516: 3512: 3511: 3508: 3505: 3503: 3500: 3498: 3494: 3493: 3491: 3489: 3485: 3479: 3476: 3474: 3470: 3469: 3466: 3463: 3461: 3458: 3456: 3452: 3451: 3449: 3447: 3446:Biliary tract 3443: 3437: 3434: 3432: 3429: 3427: 3423: 3422: 3419: 3416: 3414: 3411: 3409: 3405: 3404: 3401: 3398: 3396: 3393: 3389: 3388:Fibrolamellar 3386: 3385: 3384: 3381: 3379: 3375: 3374: 3372: 3370: 3366: 3363: 3361: 3357: 3347: 3344: 3342: 3339: 3338: 3336: 3332: 3322: 3319: 3318: 3316: 3314: 3310: 3304: 3301: 3299: 3296: 3294: 3291: 3288: 3287: 3284: 3281: 3279: 3276: 3274: 3270: 3267: 3265: 3262: 3260: 3257: 3254: 3253: 3250: 3246: 3245:Peutz–Jeghers 3242: 3238: 3234: 3230: 3226: 3223: 3221: 3217: 3216: 3214: 3212: 3208: 3202: 3199: 3197: 3194: 3193: 3191: 3189: 3185: 3177: 3174: 3173: 3172: 3169: 3168: 3166: 3164: 3160: 3157: 3155: 3151: 3141: 3138: 3136: 3133: 3129: 3128:MALT lymphoma 3126: 3125: 3124: 3121: 3119: 3116: 3114: 3111: 3110: 3108: 3106: 3102: 3096: 3093: 3091: 3088: 3087: 3085: 3083: 3079: 3076: 3074: 3070: 3067: 3065: 3061: 3057: 3050: 3045: 3043: 3038: 3036: 3031: 3030: 3027: 3014: 3010: 3009: 3005: 3004: 3001: 2997: 2990: 2986: 2985: 2981: 2979: 2975: 2974: 2970: 2968: 2964: 2963: 2959: 2957: 2953: 2949: 2948: 2944: 2942: 2938: 2937: 2933: 2929: 2927: 2923: 2922: 2918: 2914: 2912: 2908: 2904: 2900: 2896: 2895: 2891: 2887: 2886: 2883: 2878: 2874: 2868: 2865: 2862: 2859: 2856: 2853: 2851: 2848: 2846: 2843: 2840: 2839: 2835: 2833: 2830: 2829: 2825: 2819: 2815: 2810: 2805: 2801: 2797: 2793: 2789: 2785: 2779: 2775: 2771: 2767: 2763: 2758: 2753: 2748: 2743: 2740:(4): 315–20. 2739: 2735: 2731: 2726: 2722: 2718: 2714: 2710: 2706: 2702: 2698: 2694: 2687: 2682: 2681: 2677: 2669: 2665: 2661: 2657: 2653: 2649: 2645: 2641: 2634: 2631: 2626: 2622: 2617: 2612: 2607: 2602: 2598: 2594: 2591:(5): e64102. 2590: 2586: 2582: 2575: 2572: 2567: 2563: 2559: 2555: 2551: 2547: 2540: 2538: 2534: 2531: 2527: 2524: 2519: 2516: 2511: 2507: 2502: 2497: 2493: 2489: 2486:(4): FSO676. 2485: 2481: 2480:Future Sci OA 2477: 2470: 2467: 2462: 2458: 2452: 2449: 2443: 2440: 2435: 2431: 2425: 2422: 2417: 2413: 2409: 2402: 2399: 2394: 2390: 2386: 2382: 2378: 2374: 2367: 2364: 2359: 2355: 2350: 2345: 2341: 2337: 2333: 2329: 2325: 2318: 2315: 2310: 2306: 2301: 2296: 2292: 2288: 2284: 2277: 2274: 2269: 2265: 2261: 2257: 2253: 2249: 2245: 2241: 2237: 2233: 2226: 2224: 2222: 2220: 2216: 2211: 2207: 2203: 2199: 2195: 2191: 2187: 2183: 2179: 2175: 2168: 2165: 2160: 2156: 2152: 2148: 2143: 2138: 2134: 2130: 2126: 2119: 2117: 2113: 2108: 2102: 2098: 2091: 2089: 2087: 2083: 2078: 2074: 2070: 2066: 2062: 2058: 2050: 2047: 2042: 2038: 2034: 2030: 2026: 2022: 2018: 2014: 2007: 2004: 1999: 1995: 1991: 1987: 1986:J Med Insight 1980: 1978: 1974: 1969: 1965: 1960: 1955: 1951: 1947: 1944:(2): 301–16. 1943: 1939: 1935: 1928: 1925: 1922: 1918: 1914: 1909: 1904: 1900: 1896: 1892: 1885: 1882: 1877: 1873: 1869: 1865: 1861: 1857: 1850: 1847: 1842: 1838: 1834: 1830: 1823: 1820: 1815: 1811: 1807: 1803: 1799: 1795: 1788: 1785: 1780: 1776: 1772: 1768: 1761: 1758: 1753: 1749: 1745: 1741: 1738:(4): 509–14. 1737: 1733: 1726: 1723: 1720: 1715: 1713: 1711: 1709: 1705: 1700: 1696: 1693:(3): 189–92. 1692: 1688: 1681: 1679: 1675: 1670: 1666: 1662: 1658: 1654: 1650: 1647:(9): 705–12. 1646: 1642: 1635: 1633: 1631: 1629: 1625: 1620: 1616: 1612: 1608: 1604: 1600: 1596: 1592: 1585: 1583: 1581: 1579: 1575: 1570: 1566: 1561: 1556: 1552: 1548: 1544: 1540: 1536: 1529: 1526: 1521: 1517: 1512: 1507: 1503: 1499: 1495: 1491: 1487: 1480: 1478: 1474: 1469: 1465: 1460: 1455: 1451: 1447: 1443: 1439: 1435: 1428: 1426: 1422: 1417: 1413: 1409: 1405: 1401: 1397: 1393: 1390:(in German). 1389: 1382: 1379: 1374: 1370: 1365: 1360: 1355: 1350: 1346: 1342: 1338: 1330: 1327: 1321: 1318: 1313: 1309: 1305: 1301: 1297: 1293: 1286: 1283: 1278: 1274: 1270: 1266: 1262: 1258: 1254: 1250: 1249:Virchows Arch 1246: 1239: 1236: 1231: 1227: 1223: 1219: 1212: 1209: 1204: 1200: 1196: 1192: 1189:(2): 527–32. 1188: 1184: 1176: 1174: 1172: 1170: 1166: 1161: 1157: 1153: 1149: 1145: 1141: 1134: 1132: 1130: 1126: 1121: 1115: 1111: 1104: 1102: 1100: 1098: 1096: 1094: 1092: 1090: 1088: 1086: 1084: 1082: 1080: 1076: 1071: 1067: 1062: 1057: 1052: 1047: 1043: 1039: 1035: 1028: 1025: 1019: 1017: 1013: 1010: 1008: 999: 997: 994: 992: 987: 984: 981: 979: 973: 971: 967: 962: 958: 954: 951: 947: 943: 939: 934: 932: 928: 924: 920: 916: 912: 907: 904: 900: 896: 887: 880: 878: 876: 872: 868: 864: 860: 856: 852: 848: 844: 840: 836: 829: 827: 825: 821: 817: 812: 807: 803: 799: 790: 788: 786: 781: 777: 773: 769: 765: 757: 752: 747: 743: 739: 735: 731: 728: 724: 720: 718: 717:Calcification 714: 710: 706: 702: 698: 690: 683: 682:hypervascular 679: 674: 670: 668: 664: 656: 654: 652: 647: 645: 641: 637: 633: 629: 625: 621: 616: 613: 609: 605: 601: 597: 593: 588: 586: 582: 579:staining for 578: 573: 571: 570: 565: 557: 550: 546: 542: 535: 533: 526: 524: 522: 520: 517: 513: 509: 505: 497: 492: 489: 485: 481: 477: 476: 475: 473: 469: 465: 461: 456: 454: 450: 446: 442: 438: 434: 430: 426: 422: 417: 415: 411: 407: 403: 399: 395: 392: 388: 384: 380: 376: 372: 368: 364: 360: 359: 350: 348: 346: 342: 338: 334: 330: 327: 326:mitochondrial 323: 319: 315: 311: 307: 303: 300: 297: 293: 292:paraganglioma 290: 286: 283: 279: 275: 271: 263: 261: 259: 255: 251: 246: 244: 240: 236: 232: 228: 227:cell division 224: 220: 217:, 20% in the 216: 212: 208: 204: 200: 192: 190: 188: 184: 180: 176: 172: 164: 162: 159: 157: 156:smooth muscle 153: 149: 144: 139: 137: 133: 129: 125: 122: 114: 112: 110: 106: 102: 99:gene (85%), 98: 94: 90: 89:smooth muscle 86: 82: 79: 75: 71: 63: 60: 58: 54: 51: 48: 46: 42: 37: 33: 28: 23: 4361: 4349: 4337: 4324: 4323: 4270: 4248: 4236: 4224: 4197: 4185: 4173: 4161: 4149: 4137: 4130:TNF receptor 4100: 4088: 4055: 3992: 3973: 3963: 3951: 3934: 3910: 3882: 3866: 3854: 3809: 3786: 3763: 3740: 3728: 3708: 3696: 3680: 3660: 3648: 3621:deficiencies 3513: 3495: 3471: 3453: 3424: 3406: 3376: 3340: 3289: 3255: 3229:hyperplastic 3218: 3211:Colon/rectum 3006: 2982: 2971: 2960: 2945: 2930: 2915: 2888: 2837: 2791: 2787: 2737: 2733: 2696: 2692: 2643: 2639: 2633: 2588: 2584: 2574: 2552:(1): 15–34. 2549: 2545: 2518: 2483: 2479: 2469: 2460: 2451: 2442: 2433: 2424: 2415: 2411: 2401: 2376: 2372: 2366: 2331: 2327: 2317: 2290: 2286: 2276: 2235: 2231: 2180:(6): 351–8. 2177: 2173: 2167: 2132: 2128: 2096: 2060: 2056: 2049: 2019:(5): 713–6. 2016: 2012: 2006: 1989: 1985: 1941: 1937: 1927: 1898: 1894: 1884: 1859: 1855: 1849: 1835:(4): 291–2. 1832: 1828: 1822: 1800:(1): 27–32. 1797: 1793: 1787: 1770: 1766: 1760: 1735: 1731: 1725: 1690: 1686: 1644: 1640: 1594: 1590: 1542: 1538: 1528: 1493: 1489: 1444:(1): 43–52. 1441: 1438:J Intern Med 1437: 1394:(6): 430–7. 1391: 1387: 1381: 1344: 1340: 1329: 1320: 1295: 1291: 1285: 1252: 1248: 1238: 1221: 1217: 1211: 1186: 1182: 1143: 1139: 1109: 1041: 1037: 1027: 1014: 1011: 1003: 1000:Epidemiology 995: 988: 985: 982: 974: 949: 935: 911:chemotherapy 908: 895:anatomically 892: 869:, malignant 833: 794: 761: 751:spindle cell 732: 721: 695: 660: 648: 617: 589: 585:spindle cell 574: 567: 562: 530: 515: 511: 503: 501: 483: 471: 470:function of 463: 457: 452: 448: 444: 418: 390: 378: 374: 362: 356: 354: 267: 247: 196: 168: 160: 140: 118: 73: 69: 68: 3631:(including 3473:gallbladder 3426:hyperplasia 2699:(1): 13–9. 2379:(1): 61–4. 2373:US Oncology 2013:Surg Endosc 1856:Br J Radiol 1324:AJCC manual 1255:(1): 1–12. 957:neoadjuvant 931:avapritinib 923:regorafenib 802:cavitations 791:Large GISTs 758:Small GISTs 713:cavitations 608:pathologist 564:CT scanning 410:melanocytes 402:bone marrow 396:, found by 78:mesenchymal 3834:(including 3559:Peritoneum 2984:DiseasesDB 2734:Cancer Sci 2328:Oncologist 1687:Radiat Med 927:ripretinib 881:Management 847:peritoneum 835:Malignancy 824:gadolinium 705:radiopaque 663:metastasis 651:sequencing 644:mast cells 624:antibodies 622:(specific 604:microscope 572:section). 545:Endoscopic 478:KIT-D816V 419:The c-KIT 406:mast cells 312:, and the 287:and extra- 270:hereditary 211:epithelial 179:metastases 121:epithelial 91:pacemaker 4187:TNFRSF13B 4175:TNFRSF13C 4151:TNFRSF13B 3518:neoplasms 3455:bile duct 3378:malignant 3360:Accessory 3290:Neoplasm: 3273:Gardner's 3196:Carcinoid 3082:Esophagus 2252:0012-6667 2194:1759-4782 2129:Br J Surg 1388:Pathologe 1183:Radiology 1020:Citations 944:based on 919:sunitinib 772:submucosa 746:β-catenin 667:malignant 634:, DOG-1, 581:β-catenin 575:Negative 569:radiology 536:Diagnosis 361:pathway. 302:mutations 285:chondroma 282:pulmonary 243:mesentery 223:esophagus 205:; unlike 81:neoplasms 45:Specialty 4394:Category 4375:See also 4305:Integrin 4139:TNFRSF1A 4077:JAK-STAT 4011:Endoglin 3488:Pancreas 3259:Juvenile 3233:juvenile 3188:Appendix 3064:GI tract 3008:Orphanet 2818:37655207 2809:10467260 2774:31070671 2766:12824897 2757:11160165 2713:12704441 2668:40111082 2660:21358303 2625:23717541 2585:PLOS ONE 2566:19248968 2526:Archived 2510:33815822 2393:78453531 2358:22643537 2309:22831984 2268:43794982 2260:22994537 2210:12733166 2202:22525709 2151:25970743 2077:22951033 2041:12838290 2033:16502196 1968:22365521 1917:20555113 1876:18628330 1752:17711447 1661:11034250 1619:26071847 1611:15855894 1569:33999334 1520:23599150 1468:19522824 1408:20848108 1373:30788170 1312:12586147 1269:11213830 1230:11005253 1203:12563150 1160:17090188 1070:19653355 978:adjuvant 961:adjuvant 915:imatinib 867:lymphoma 640:vimentin 587:tumors. 421:molecule 383:mutation 296:germline 264:Genetics 258:motility 203:sarcomas 148:sarcomas 50:Oncology 4298:AGM3, 6 4199:TNFRSF6 4163:TNFRSF5 3803:Class F 3780:Class C 3757:Class B 3642:Class A 3633:hormone 3225:adenoma 3105:Stomach 2978:D046152 2956:M8936/3 2952:M8936/0 2721:3814815 2616:3663836 2593:Bibcode 2501:8015663 2349:3399657 2159:2810885 1992:(129). 1959:3386646 1841:9891768 1814:8659399 1779:9891770 1699:9278378 1560:9235413 1511:3701292 1459:3129547 1416:9295361 1364:6351301 1277:7598241 1061:2721251 1007:sarcoma 946:bcr-abl 843:omentum 798:necrose 776:luminal 774:from a 753:tumors. 657:Imaging 549:stomach 441:enzymes 404:cells, 389:of the 324:in the 289:adrenal 215:stomach 201:, i.e. 126:of the 83:of the 4351:BMPR1A 4102:CSF2RA 4057:GUCY2D 4033:TGFBR2 4029:TGFBR1 3742:PTGER2 3515:cystic 3408:benign 2967:606764 2911:2F7A.0 2903:2B5F.2 2816:  2806:  2772:  2764:  2754:  2719:  2711:  2666:  2658:  2623:  2613:  2564:  2508:  2498:  2391:  2356:  2346:  2307:  2266:  2258:  2250:  2208:  2200:  2192:  2157:  2149:  2103:  2075:  2039:  2031:  1966:  1956:  1915:  1874:  1839:  1812:  1777:  1750:  1697:  1669:663887 1667:  1659:  1617:  1609:  1567:  1557:  1518:  1508:  1466:  1456:  1414:  1406:  1371:  1361:  1310:  1275:  1267:  1228:  1201:  1158:  1116:  1068:  1058:  851:pleura 768:mucosa 638:, and 636:desmin 600:biopsy 592:biopsy 516:PDGFrA 310:PDGFRA 124:tumors 101:PDGFRA 4363:IL2RG 4339:PTCH1 4192:CVID2 4180:CVID4 4019:SMAD4 4015:Alk-1 3994:AMHR2 3953:NTRK1 3912:FGFR3 3884:FGFR2 3868:FGFR1 3765:PTH1R 3730:AVPR2 3710:EDNRB 3698:GnRHR 3662:LHCGR 3369:Liver 3154:Lower 3073:Upper 3013:44890 2989:33849 2947:ICD-O 2941:C49.A 2936:10-CM 2770:S2CID 2717:S2CID 2689:(PDF) 2664:S2CID 2389:S2CID 2264:S2CID 2232:Drugs 2206:S2CID 2155:S2CID 2037:S2CID 1665:S2CID 1615:S2CID 1412:S2CID 1308:S2CID 1273:S2CID 970:stoma 950:c-KIT 855:lungs 839:liver 806:lumen 711:. If 628:CD117 606:by a 512:c-KIT 504:c-KIT 484:c-KIT 472:c-KIT 464:c-KIT 460:exons 453:c-KIT 449:c-KIT 414:CD117 379:c-KIT 363:c-KIT 358:c-KIT 306:c-KIT 241:, or 231:liver 177:, or 109:stain 74:GISTs 4326:EDAR 4309:LAD1 4272:LDLR 4250:LRP5 4238:LRP4 4226:LRP2 3985:STPK 3936:INSR 3856:ROR2 3811:FZD4 3788:CASR 3682:FSHR 3650:TSHR 3313:Anus 2973:MeSH 2962:OMIM 2907:2E87 2899:2B5B 2814:PMID 2762:PMID 2709:PMID 2656:PMID 2621:PMID 2562:PMID 2506:PMID 2354:PMID 2305:PMID 2256:PMID 2248:ISSN 2198:PMID 2190:ISSN 2147:PMID 2101:ISBN 2073:PMID 2029:PMID 1990:2024 1964:PMID 1913:PMID 1872:PMID 1837:PMID 1810:PMID 1775:PMID 1748:PMID 1695:PMID 1657:PMID 1607:PMID 1565:PMID 1516:PMID 1464:PMID 1404:PMID 1369:PMID 1265:PMID 1226:PMID 1199:PMID 1156:PMID 1114:ISBN 1066:PMID 929:and 897:and 857:and 845:and 770:and 744:for 632:CD34 514:and 427:, a 345:SDHB 343:and 341:SDHC 337:SDHD 318:dyad 136:CD34 105:BRAF 4221:LRP 4115:MPL 3965:KIT 3847:RTK 2932:ICD 2926:D37 2917:ICD 2890:ICD 2804:PMC 2796:doi 2752:PMC 2742:doi 2701:doi 2648:doi 2611:PMC 2601:doi 2554:doi 2496:PMC 2488:doi 2461:FDA 2381:doi 2344:PMC 2336:doi 2295:doi 2240:doi 2182:doi 2137:doi 2133:102 2065:doi 2061:215 2021:doi 1994:doi 1954:PMC 1946:doi 1903:doi 1864:doi 1802:doi 1798:167 1740:doi 1649:doi 1599:doi 1555:PMC 1547:doi 1543:476 1506:PMC 1498:doi 1454:PMC 1446:doi 1442:266 1396:doi 1359:PMC 1349:doi 1300:doi 1257:doi 1253:438 1191:doi 1187:226 1148:doi 1144:130 1056:PMC 1046:doi 811:MRI 482:in 445:scf 433:DNA 391:KIT 375:scf 304:in 294:), 97:KIT 4396:: 4333:) 4307:: 4296:: 4261:, 4257:, 4223:: 4090:GH 4087:: 4048:GC 4009:: 3972:, 3927:, 3923:, 3919:, 3903:, 3899:, 3895:, 3891:, 3875:, 3721:, 3717:, 3689:, 3673:, 3669:, 3521:: 3247:, 3243:, 3239:, 3235:, 3231:, 3227:, 3011:: 2987:: 2976:: 2965:: 2954:- 2950:: 2939:: 2924:: 2921:10 2909:, 2905:, 2901:, 2897:: 2894:11 2812:. 2802:. 2792:15 2790:. 2786:. 2768:. 2760:. 2750:. 2738:94 2736:. 2732:. 2715:. 2707:. 2695:. 2691:. 2662:. 2654:. 2644:35 2642:. 2619:. 2609:. 2599:. 2587:. 2583:. 2560:. 2550:23 2548:. 2536:^ 2504:. 2494:. 2482:. 2478:. 2459:. 2432:. 2410:. 2387:. 2375:. 2352:. 2342:. 2332:17 2330:. 2326:. 2303:. 2291:23 2289:. 2285:. 2262:. 2254:. 2246:. 2236:72 2234:. 2218:^ 2204:. 2196:. 2188:. 2176:. 2153:. 2145:. 2131:. 2127:. 2115:^ 2085:^ 2071:. 2059:. 2035:. 2027:. 2017:20 2015:. 1988:. 1976:^ 1962:. 1952:. 1942:21 1940:. 1936:. 1911:. 1899:21 1897:. 1893:. 1870:. 1860:81 1858:. 1833:87 1831:. 1808:. 1796:. 1771:87 1769:. 1746:. 1736:51 1734:. 1707:^ 1691:15 1689:. 1677:^ 1663:. 1655:. 1643:. 1627:^ 1613:. 1605:. 1595:12 1593:. 1577:^ 1563:. 1553:. 1541:. 1537:. 1514:. 1504:. 1494:26 1492:. 1488:. 1476:^ 1462:. 1452:. 1440:. 1436:. 1424:^ 1410:. 1402:. 1392:31 1367:. 1357:. 1345:10 1343:. 1339:. 1306:. 1296:15 1294:. 1271:. 1263:. 1251:. 1247:. 1222:15 1220:. 1197:. 1185:. 1168:^ 1154:. 1142:. 1128:^ 1078:^ 1064:. 1054:. 1042:15 1040:. 1036:. 933:. 925:, 921:, 917:, 877:. 853:, 841:, 785:CT 727:CT 646:. 523:. 408:, 347:. 339:, 260:. 237:, 173:, 4370:) 4366:( 4358:) 4354:( 4346:) 4342:( 4329:( 4279:) 4275:( 4265:) 4253:( 4245:) 4241:( 4233:) 4229:( 4206:) 4202:( 4194:) 4190:( 4182:) 4178:( 4170:) 4166:( 4158:) 4154:( 4146:) 4142:( 4121:) 4117:( 4109:) 4105:( 4097:) 4093:( 4064:) 4060:( 4039:) 4035:( 4031:/ 4025:) 4021:( 4017:/ 4013:/ 4001:) 3997:( 3976:) 3968:( 3960:) 3956:( 3948:) 3939:( 3931:) 3915:( 3907:) 3887:( 3879:) 3871:( 3863:) 3859:( 3839:) 3818:) 3814:( 3795:) 3791:( 3772:) 3768:( 3749:) 3745:( 3737:) 3733:( 3725:) 3713:( 3705:) 3701:( 3693:) 3685:( 3677:) 3665:( 3657:) 3653:( 3635:) 3611:e 3604:t 3597:v 3499:: 3475:: 3457:: 3428:: 3410:: 3380:: 3271:/ 3222:: 3048:e 3041:t 3034:v 2934:- 2919:- 2892:- 2882:D 2820:. 2798:: 2776:. 2744:: 2723:. 2703:: 2697:9 2670:. 2650:: 2627:. 2603:: 2595:: 2589:8 2568:. 2556:: 2512:. 2490:: 2484:7 2418:. 2416:3 2395:. 2383:: 2377:5 2360:. 2338:: 2311:. 2297:: 2270:. 2242:: 2212:. 2184:: 2178:9 2161:. 2139:: 2109:. 2079:. 2067:: 2043:. 2023:: 2000:. 1996:: 1970:. 1948:: 1919:. 1905:: 1878:. 1866:: 1843:. 1816:. 1804:: 1781:. 1754:. 1742:: 1701:. 1671:. 1651:: 1645:7 1621:. 1601:: 1571:. 1549:: 1522:. 1500:: 1470:. 1448:: 1418:. 1398:: 1375:. 1351:: 1314:. 1302:: 1279:. 1259:: 1232:. 1205:. 1193:: 1162:. 1150:: 1122:. 1072:. 1048:: 373:( 308:/ 72:(

Index


Specialty
Oncology
Differential diagnosis
Ectopic pancreas
mesenchymal
neoplasms
gastrointestinal tract
smooth muscle
interstitial cell of Cajal
KIT
PDGFRA
BRAF
stain
epithelial
tumors
gastrointestinal tract
Histopathologists
CD34
molecular basis
sarcomas
leiomyosarcomas
smooth muscle
trouble swallowing
gastrointestinal bleeding
metastases
Intestinal obstruction
abdominal pain
connective tissue
sarcomas

Text is available under the Creative Commons Attribution-ShareAlike License. Additional terms may apply.

↑